End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
23.26 CNY | +2.20% | +1.44% | +11.67% |
Strengths
- Growth is a substantial asset for the company, as anticipated by dedicated analysts. Within the next three years, growth is estimated to reach 49% by 2026.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The opinion of analysts covering the stock has improved over the past four months.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- Revenue estimates are regularly revised downwards for the current and coming years.
- Over the past twelve months, analysts' opinions have been revised negatively.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Sector: Appliances, Tools & Housewares
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+11.67% | 428M | - | ||
+30.93% | 32.14B | C | ||
+50.21% | 7.72B | C+ | ||
+89.61% | 6.82B | - | ||
-21.52% | 5.22B | B- | ||
+19.57% | 3.92B | C- | ||
+3.43% | 3.17B | B+ | ||
+8.77% | 3.09B | B- | ||
+0.35% | 3.07B | A- | ||
-8.16% | 2.79B | D |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 603579 Stock
- Ratings Shanghai Rongtai Health Technology Corporation Limited